Advances in chemical carcinogenesis: a historical review and prospective.

The American Association for Cancer Research has been the citadel for communicating research on chemical carcinogens for over a century. It therefore seems appropriate that a review of chemical carcinogenesis inaugurates a series of articles highlighting advances in understanding, treating, and

[1]  T. Sugimura.  Studies on environmental chemical carcinogenesis in Japan. , 1986, Science.

[2]  R. Tompkins,et al.  Nitric oxide production is intensely and persistently increased in tissue by thermal injury. , 1994, The Biochemical journal.

[3]  M. Barbacid,et al.  Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations , 1983, Nature.

[4]  D. Nebert,et al.  The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis , 2006, Nature Reviews Cancer.

[5]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[6]  E. Friedberg,et al.  Enzymatic degradation of uracil-containing DNA. II. Evidence for N-glycosidase and nuclease activities in unfractionated extracts of Bacillus subtilis , 1976, Journal of virology.

[7]  J. Huff,et al.  Weight of evidence versus weight of speculation to evaluate the alpha2u-globulin hypothesis. , 1997, Environmental health perspectives.

[8]  E. Miller,et al.  The Presence and Significance of Bound Aminoazo Dyes in the Livers of Rats Fed p-Dimethylaminoazobenzene , 1947 .

[9]  M. Sporn,et al.  Aflatoxin B1: Binding to DNA in vitro and Alteration of RNA Metabolism in vivo , 1966, Science.

[10]  H. Schreiber,et al.  Induction of lung cancer in germfree, specific-pathogen-free, and infected rats by N-nitrosoheptamethyleneimine: enhancement by respiratory infection. , 1972, Journal of the National Cancer Institute.

[11]  L. Coussens,et al.  Tumor stroma and regulation of cancer development. , 2006, Annual review of pathology.

[12]  Peter A. Jones,et al.  Inhibition of DNA methylation by chemical carcinogens in vitro , 1983, Cell.

[13]  Barry Halliwell,et al.  DNA damage by oxygen‐derived species Its mechanism and measurement in mammalian systems , 1991, FEBS letters.

[14]  T. Omura,et al.  A new cytochrome in liver microsomes. , 1962, The Journal of biological chemistry.

[15]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[16]  A. Levine,et al.  The p53 tumour suppressor gene , 1991, Nature.

[17]  O. Warburg.  On respiratory impairment in cancer cells. , 1956, Science.

[18]  R. Prehn,et al.  Immunity to methylcholanthrene-induced sarcomas. , 1957, Journal of the National Cancer Institute.

[19]  R. Montesano,et al.  Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa. , 2006, Carcinogenesis.

[20]  K Yamagiwa,et al.  Experimental study of the pathogenesis of carcinoma , 1977, CA: a cancer journal for clinicians.

[21]  J. Wands,et al.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa , 1991, Nature.

[22]  J. Miller,et al.  The metabolism of methylated aminoazo dyes. VI. Intracellular distribution and properties of the demethylase system. , 1957, Cancer research.

[23]  G. P. Wheeler,et al.  STUDIES WITH MUSTARDS. VII. EFFECTS OF ALKYLATING AGENTS IN VITRO AND IN VIVO UPON THE THERMAL PROPERTIES OF DEOXYRIBONUCLEIC ACIDS FROM SENSITIVE AND RESISTANT PLASMACYTOMAS. , 1965, Cancer research.

[24]  W. M. COURT BROWN.  Radiation carcinogenesis. , 1963, The Practitioner.

[25]  A. Balmain,et al.  Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene , 1983, Nature.

[26]  J. M. Barnes,et al.  Carcinogenic Activity of Aflatoxin to Rats , 1964, Nature.

[27]  M. Kimmey,et al.  DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. , 1992, Gastroenterology.

[28]  P. Cerutti.  Prooxidant states and tumor promotion. , 1985, Science.

[29]  Chikahide Masutani,et al.  The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η , 1999, Nature.

[30]  M. Radman,et al.  Specialized DNA Polymerases, Cellular Survival, and the Genesis of Mutations , 2002, Science.

[31]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[32]  J. Essigmann,et al.  In vivo mutagenesis by O6-methylguanine built into a unique site in a viral genome. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[33]  N. Masuda,et al.  Possible involvement of GTP‐binding proteins in growth regulation of human epidermoid carcinoma cell line A431 , 1991, FEBS letters.

[34]  C. Harris,et al.  Carcinogenic polynuclear hydrocarbons bind to macromolecules in cultured human bronchi , 1974, Nature.

[35]  B Nyberg,et al.  Heat-induced deamination of cytosine residues in deoxyribonucleic acid. , 1974, Biochemistry.

[36]  J. Cairns.  The origin of human cancers , 1981, Nature.

[37]  J. W. Cook,et al.  106. The isolation of a cancer-producing hydrocarbon from coal tar. Parts I, II, and III , 1933 .

[38]  F. Crick,et al.  Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid , 1974, Nature.

[39]  E. A. Graham,et al.  Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. , 1950, Journal of the American Medical Association.

[40]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[41]  L. Sachs.  The Mechanism of Carcinogenesis , 1972 .

[42]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[43]  R. V. von Borstel,et al.  Janus carcinogens and mutagens. , 1998, Mutation research.

[44]  A. Knudson.  Hereditary cancer, oncogenes, and antioncogenes. , 1985, Cancer research.

[45]  L. Fink,et al.  Chemical carcinogens and RNA. , 1971, Cancer Research.

[46]  Lei Li,et al.  Repair of DNA interstrand cross-links: interactions between homology-dependent and homology-independent pathways. , 2006, DNA repair.

[47]  M. Tang,et al.  Preferential Formation of Benzo[a]pyrene Adducts at Lung Cancer Mutational Hotspots in P53 , 1996, Science.

[48]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Miller,et al.  The metabolism of 4-dimethylaminoazobenzene by rat liver homogenates. , 1948, The Journal of biological chemistry.

[50]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[51]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. , 1993, Cell.

[52]  R. Preston.  Mechanistic data and cancer risk assessment: The need for quantitative molecular endpoints , 2005, Environmental and molecular mutagenesis.

[53]  R. Metcalf,et al.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas. , 1991, Nature.

[54]  A. Levine,et al.  Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells , 1979, Cell.

[55]  M. Perucho.  Cancer of the microsatellite mutator phenotype. , 1996, Biological chemistry.

[56]  S. Hecht,et al.  Tobacco-specific nitrosamines: formation from nicotine in vitro and during tobacco curing and carcinogenicity in strain A mice. , 1978, Journal of the National Cancer Institute.

[57]  T. Lindahl,et al.  Rate of depurination of native deoxyribonucleic acid. , 1972, Biochemistry.

[58]  H. Bartsch,et al.  Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. , 1994, Mutation research.

[59]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[60]  S. Belinsky,et al.  High- to low-dose extrapolation: critical determinants involved in the dose response of carcinogenic substances. , 1987, Environmental health perspectives.

[61]  P. Nelson,et al.  Phytoestrogens: perpetrators or protectors? , 2007, Future oncology.

[62]  F. Hanaoka,et al.  Mechanisms of accurate translesion synthesis by human DNA polymerase η , 2000, The EMBO journal.

[63]  K Raja,et al.  Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. , 2000, Cancer research.

[64]  H. Skipper,et al.  Studies with mustards. III. In vivo fixation of C14 from nitrogen mustard-C14H3 in nucleic acid fractions of animal tissues. , 1957, Archives of biochemistry and biophysics.

[65]  C. Harris,et al.  Chemical and physical carcinogenesis: advances and perspectives for the 1990s. , 1991, Cancer research.

[66]  Robert A. Weinberg,et al.  Metastasis genes: A progression puzzle , 2002, Nature.

[67]  Y. Doki,et al.  Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[68]  C. Heidelberger.  Chemical carcinogenesis , 1977, Annual review of biochemistry.

[69]  A. Balmain,et al.  Carcinogenesis in mouse and human cells: parallels and paradoxes. , 2000, Carcinogenesis.

[70]  L. Loeb,et al.  Efficiency of carcinogenesis with and without a mutator mutation , 2006, Proceedings of the National Academy of Sciences.

[71]  A. Grollman,et al.  Mutagenesis by 8-oxoguanine: an enemy within. , 1993, Trends in genetics : TIG.

[72]  M. Poirier.  Chemical-induced DNA damage and human cancer risk , 2004, Nature Reviews Cancer.

[73]  I. Rusyn,et al.  Epigenetic aspects of genotoxic and non‐genotoxic hepatocarcinogenesis: Studies in rodents , 2008, Environmental and molecular mutagenesis.

[74]  M. Sporn,et al.  Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). , 1976, Federation proceedings.

[75]  R. Setlow,et al.  THE DISAPPEARANCE OF THYMINE DIMERS FROM DNA: AN ERROR-CORRECTING MECHANISM. , 1964, Proceedings of the National Academy of Sciences of the United States of America.

[76]  L. Loeb,et al.  Endogenous carcinogenesis: molecular oncology into the twenty-first century--presidential address. , 1989, Cancer research.

[77]  R. Gupta,et al.  32P-labeling test for DNA damage. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[78]  Edward J Calabrese,et al.  Toxicological awakenings: the rebirth of hormesis as a central pillar of toxicology. , 2005, Toxicology and applied pharmacology.

[79]  Carissa A. Sanchez,et al.  Evolution of neoplastic cell lineages in Barrett oesophagus , 1999, Nature Genetics.

[80]  A. Rustgi,et al.  The genetics of hereditary colon cancer. , 2007, Genes & development.

[81]  Ronald W. Davis,et al.  Erratum: Initial sequencing and analysis of the human genome: International Human Genome Sequencing Consortium (Nature (2001) 409 (860-921)) , 2001 .

[82]  L. Hood,et al.  Internal amino acid sequence analysis of proteins separated by one- or two-dimensional gel electrophoresis after in situ protease digestion on nitrocellulose. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[83]  R. Doll,et al.  Smoking and carcinoma of the lung; preliminary report. , 1950, British medical journal.

[84]  T. Kunkel,et al.  RNA-templated DNA repair , 2007, Nature.

[85]  J. Miller,et al.  N-Hydroxylation: A new metabolic reaction observed in the rat with the carcinogen 2-acetylaminofluorene. , 1960, The Journal of biological chemistry.

[86]  E. Friedberg,et al.  DNA Repair and Mutagenesis , 2006 .

[87]  O. Avery,et al.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES , 1944, The Journal of experimental medicine.

[88]  J. Kleinjans,et al.  Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling. , 2004, Carcinogenesis.

[89]  B. Sani,et al.  The content of the principal protein target of a hepatic carcinogen in liver tumors. , 1973, Cancer research.

[90]  L. Aaltonen,et al.  Somatic microsatellite mutations as molecular tumor clocks , 1996, Nature Medicine.

[91]  James Hopkins,et al.  IARC monographs on the evaluation of carcinogenic risks to humans: Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42. Supplement 7. IARC, Lyon, 1987. pp. 440. Sw.fr 65.00. ISBN 92-833-1411-0 , 1989 .

[92]  D. Lane,et al.  T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.

[93]  J Taylor,et al.  Global approaches to quantitative analysis of gene-expression patterns observed by use of two-dimensional gel electrophoresis. , 1984, Clinical chemistry.

[94]  P. Roller,et al.  Enzymatic conversion of benzo(a)pyrene leading predominantly to the diol-epoxide r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene through a single enantiomer of r-7, t-8-dihydroxy-7,8-dihydrobenzo(a)pyrene. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[95]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[96]  S. Yuspa,et al.  Chemical carcinogenesis: from animal models to molecular models in one decade. , 1988, Advances in cancer research.

[97]  J. Coxhead,et al.  Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[98]  C. Klein.  Single cell amplification methods for the study of cancer and cellular ageing , 2005, Mechanisms of Ageing and Development.

[99]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[100]  S. Aaronson,et al.  Transformation and Virus Growth by Murine Sarcoma Viruses in Human Cells , 1970, Nature.

[101]  Theodor Boveri.  Zur Frage der Entstehung maligner Tumoren , 1914 .

[102]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[103]  B. Weichman.  Inflammation: basic principles and clinical correlates , 1988, Agents and Actions.

[104]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[105]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[106]  P. Hanawalt,et al.  DNA repair in an active gene: Removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall , 1985, Cell.

[107]  J. Hesser,et al.  The relation of infection with the hepatitis B agent to primary hepatic carcinoma. , 1975, The American journal of pathology.

[108]  T. Lindahl.  Instability and decay of the primary structure of DNA , 1993, Nature.

[109]  L. Loeb.  Apurinic sites as mutagenic intermediates , 1985, Cell.

[110]  C. Harris,et al.  Interindividual variation in binding of benzo[a]pyrene to DNA in cultured human bronchi. , 1976, Science.

[111]  G. B. Pierce,et al.  Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[112]  L. Loeb,et al.  Environmental and chemical carcinogenesis. , 2004, Seminars in cancer biology.

[113]  Y. Lou,et al.  Administration of green tea or caffeine enhances the disappearance of UVB-induced patches of mutant p53 positive epidermal cells in SKH-1 mice. , 2005, Carcinogenesis.

[114]  J E Talmadge,et al.  Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.

[115]  J. Essigmann,et al.  Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[116]  I. Weinstein,et al.  Detection of carcinogen–DNA adducts by radioimmunoassay , 1977, Nature.

[117]  D. Lin,et al.  Fen1 mutations result in autoimmunity, chronic inflammation and cancers , 2007, Nature Medicine.

[118]  Richard D. Wood,et al.  Repair of an Interstrand DNA Cross-link Initiated by ERCC1-XPF Repair/Recombination Nuclease* , 2000, The Journal of Biological Chemistry.

[119]  R. Weinberg,et al.  Isolation of a transforming sequence from a human bladder carcinoma cell line , 1982, Cell.

[120]  Kyriacos Patatas.  Radiation , 2008, BMJ : British Medical Journal.

[121]  L. Loeb,et al.  Errors in DNA replication as a basis of malignant changes. , 1974, Cancer research.

[122]  K. Randerath.  ^ P-postlabeling test for DNA damage , 1981 .

[123]  M. Olivier,et al.  Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database , 2007, Human mutation.

[124]  P. Hanawalt.  Transcription-coupled repair and human disease. , 1994, Science.

[125]  G. Wogan.  Detection of DNA damage in studies on cancer etiology and prevention. , 1988, IARC scientific publications.

[126]  T. Kunkel,et al.  The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases , 2008, Cell Research.

[127]  I. Berenblum,et al.  The Mechanism of Carcinogenesis. A Study of the Significance of Cocarcinogenic Action and Related Phenomena , 1941 .

[128]  B. Henderson,et al.  Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma , 1992, The Lancet.

[129]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[130]  W. Hueper.  Experimental production of bladder tumors in dogs by administration of beta-naphthylamine. , 1938 .

[131]  A. Y. Lu,et al.  Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. IX. The formation of a 455-nm metabolite-cytochrome P-450 complex. , 1971, Drug metabolism and disposition: the biological fate of chemicals.

[132]  K. Mullis,et al.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. , 1987, Methods in enzymology.

[133]  F P Perera,et al.  Molecular epidemiology: recent advances and future directions. , 2000, Carcinogenesis.

[134]  P. Magee,et al.  The Production of Malignant Primary Hepatic Tumours in the Rat by Feeding Dimethylnitrosamine , 1956, British Journal of Cancer.

[135]  D. Burk,et al.  On respiratory impairment in cancer cells. , 1956, Science.

[136]  R. Shamberger,et al.  Antioxidants and Cancer , 1976 .

[137]  J. Weisburger.  Practical approaches to chemoprevention of cancer. , 1994, Drug metabolism reviews.

[138]  Andreas Luch,et al.  Nature and nurture – lessons from chemical carcinogenesis , 2005, Nature Reviews Cancer.

[139]  S. Nishimura,et al.  Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. , 1984, Nucleic acids research.

[140]  S. Hecht,et al.  Tobacco smoke carcinogens and lung cancer. , 1999, Journal of the National Cancer Institute.

[141]  K. Eckert,et al.  DNA Polymerases and Human Diseases , 2006, Radiation research.

[142]  M. Cobb,et al.  Pharmacological inhibitors of MAPK pathways. , 2002, Trends in pharmacological sciences.

[143]  R. Weinberg,et al.  The Biology of Cancer , 2006 .

[144]  J. Miller,et al.  The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. , 1956, Cancer research.

[145]  B. Sedgwick.  Repairing DNA-methylation damage , 2004, Nature Reviews Molecular Cell Biology.

[146]  E. Kennaway.  Further experiments on cancer-producing substances. , 1930, The Biochemical journal.

[147]  B. Ames,et al.  Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[148]  E. Boyland,et al.  Metabolism of polycyclic compounds: Production of dihydroxydihydroanthracene from anthracene. , 1936, The Biochemical journal.

[149]  J. Essigmann,et al.  Genetic effects of thymine glycol: site-specific mutagenesis and molecular modeling studies. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[150]  C. Wild,et al.  Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. , 2008, Annual Review of Public Health.

[151]  Y. Esaka,et al.  Separation procedures capable of revealing DNA adducts. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[152]  L. Sachs,et al.  In Vitro Cell Transformation with Chemical Carcinogens , 1963, Nature.

[153]  L. Samson,et al.  3-Methyladenine DNA glycosylase-deficient Aag null mice display unexpected bone marrow alkylation resistance. , 2002, Cancer research.

[154]  F. Hanaoka,et al.  Xeroderma pigmentosum variant (XP‐V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity , 1999, The EMBO journal.

[155]  M. Barbacid,et al.  Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[156]  H. Hennings,et al.  Studies on the mechanism of skin tumor promotion. , 1970, Cancer research.

[157]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[158]  H. Esumi,et al.  U.S.-Japan Cooperative Cancer Research Program: Seminar on Nitric Oxide Synthase and Cardnogenesis , 1994 .

[159]  J. Cleaver.  Defective Repair Replication of DNA in Xeroderma Pigmentosum , 1968, Nature.

[160]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[161]  P. Vineis,et al.  Aromatic Amines and Cancer , 1998 .

[162]  P. Modrich,et al.  Mechanisms and biological effects of mismatch repair. , 1991, Annual review of genetics.

[163]  F. Perera,et al.  A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene--DNA adducts in animal and human tissues by immunoassays. , 1982, Carcinogenesis.

[164]  R. Doll,et al.  Smoking and Carcinoma of the Lung , 1950, Acta - Unio Internationalis Contra Cancrum.

[165]  P. Farmer,et al.  Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection. , 2006, Carcinogenesis.

[166]  R. Larson,et al.  Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. , 2002, Blood.

[167]  D. Grunberger,et al.  Molecular Biology of Mutagens and Carcinogens , 1983, Springer US.

[168]  A. Y. Lu,et al.  Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. VI. Different substrate specificities of the cytochrome P450 fractions from control and phenobarbital-treated rats. , 1973, The Journal of biological chemistry.

[169]  L. Loeb,et al.  Stimulation of Ammo-acid Incorporation by Nuclear Ribonucleic Acid from Normal and Methylcholanthrene-treated Rats , 1963, Nature.

[170]  Richard D. Wood,et al.  Human DNA Repair Genes , 2001, Science.

[171]  R. Virchow.  Die krankhaften Geschwülste : dreissig Vorlesungen, gehalten während des Wintersemesters 1862-1863 an der Universität zu Berlin , 1863 .

[172]  S. Gerson.  Clinical relevance of MGMT in the treatment of cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[173]  H. L. Carrell,et al.  Benzo[a]pyrene and its analogues: structural studies of molecular strain. , 1997, Carcinogenesis.

[174]  C. Harris,et al.  Radical causes of cancer , 2003, Nature Reviews Cancer.

[175]  Lawrence D True,et al.  Human cancers express a mutator phenotype , 2006, Proceedings of the National Academy of Sciences.

[176]  R. Shamberger,et al.  Antioxidants and cancer. IV. Initiating activity of malonaldehyde as a carcinogen. , 1974, Journal of the National Cancer Institute.

[177]  C. S. Davidson,et al.  Hepatoma in Uganda. A study in geographic pathology. , 1968, Lancet.

[178]  A. Floridi.  [Metabolism of the cancer cell]. , 1972, Recenti progressi in medicina.

[179]  M Meselson,et al.  THE REPLICATION OF DNA IN ESCHERICHIA COLI. , 1958, Proceedings of the National Academy of Sciences of the United States of America.

[180]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[181]  J. Klaunig,et al.  Epigenetic mechanisms of chemical carcinogenesis , 2000, Human & experimental toxicology.